Universal reference book for medicines
Product name: DIPROSALIK В® LOTION (DIPROSALIC В® LOTION)

Active substance: betamethasone dipropionate, salicylic acid

Type: Anti-inflammatory and keratolytic drug for external use

Manufacturer: SCHERING-PLOUGH (France)
Composition, form of production and packaging
?
The solution for external use is colorless, translucent, viscous, with a characteristic smell of isopropyl alcohol, does not contain visible particles.
1 g

betamethasone dipropionate 640 Ојg,

which corresponds to the content of betamethasone 500 Ојg

salicylic acid 20 mg

Excipients: disodium edetate 0.3 mg, hypromellose 5 mg, sodium hydroxide 5 mg, isopropanol 392 mg, purified water qs to 1 g.

30 ml - a vial of a dropper plastic (1) - packs cardboard.

INSTRUCTION FOR THE SPECIALIST.

Description of the drug approved by the manufacturer for the printed edition of 2008.

PHARMACHOLOGIC EFFECT

Combined drug, the effect of which is due to its constituent components.

Betamethasone dipropionate - synthetic fluorinated GCS - has an anti-inflammatory, antipruritic and vasoconstrictive effect.

Salicylic acid with local application has keratolytic, as well as bacteriostatic and some fungicidal action.

INDICATIONS

- psoriasis of the scalp or other localization;

- seborrhea of ​​the scalp;

- other dermatoses that are amenable to GKS therapy.

DOSING MODE

Outwardly.

Apply a thin layer 2 times / day - in the morning and at night, completely covering the affected skin.
In some patients, the supporting effect can be achieved by less frequent applica- tions.
The duration of the course of treatment is determined by its effectiveness, as well as the patient's tolerance, the presence and severity of side effects.

SIDE EFFECT

Burning, itching, skin irritation, dry skin, folliculitis, hypertrichosis, acne, hypopigmentation, perioral dermatitis, allergic contact dermatitis, skin maceration, secondary infection, skin atrophy, striae, sweating, pain, skin cracks, dermatitis, purpura, telangiectasia , local hirsutism.

With local application of GCS for a long period and / or in high doses , especially in children, side effects characteristic of systemic SCS (including suppression of hypothalamic-pituitary-adrenal system function, development of Cushing's syndrome, growth retardation, insufficient increase in body weight and increased intracranial pressure).

Salicylic acid preparations can cause dermatitis.

CONTRAINDICATIONS

- Hypersensitivity to any of the components of the drug;

- Children under 2 years;

- Pregnancy;

- lactation period;

- rosacea;

- perioral dermatitis;

- bacterial, viral or fungal skin infection (pyoderma, syphilis, skin tuberculosis, Negrex simplex, chicken pox, Herpes zoster, actinomycosis, blastomycosis, sporotrichosis);

- trophic ulcers on the background of chronic venous insufficiency;

- skin tumors (skin cancer, nevus, atheroma, epithelioma, melanoma, hemangioma, xanthoma, sarcoma);

- postvaccinal skin reactions;

With caution: children under 12 years;
liver failure; long-term therapy.
PREGNANCY AND LACTATION

The safety of the use of local GCS in pregnant women is not established.

Since it has not been determined to date whether the local GCS penetrates into the mother's milk, the issue of stopping breastfeeding or using the drug should be addressed.

APPLICATION FOR VIOLATIONS OF THE FUNCTION OF KIDNEYS

With caution: liver failure.

APPLICATION FOR CHILDREN

Children are more at risk of oppression of the function of the hypothalamic-pituitary-adrenal system due to the use of local GCS than adults, because of the greater correlation between their body surface area and weight and, accordingly, increased absorption of the drug.

SPECIAL INSTRUCTIONS

If, against the background of the application of Diprosalica Lotion, skin irritation or hypersensitivity to the drug appears, treatment should be discontinued.
In case of infection, appropriate therapy should be prescribed.
Systemic absorption of GCS and salicylic acid in their local application will be the higher the large surface of the body is treated.
Appropriate precautions should be taken if prolonged use of the drug is contemplated, especially in children.
The application of salicylic acid on an open wound or damaged skin is not allowed.

When applying Diprosalica Lotion, you should not use bandages.

If dryness or irritation of the skin occurs, the drug should be discontinued.

With prolonged treatment with the drug, it is recommended to cancel it gradually.

Diprosalik Lotion is not intended for use in ophthalmology.
Avoid contact with eyes and mucous membranes.
Long-term use on the face is not recommended.

Avoid application in the anogenital area.

Application in pediatrics.

Children are more at risk of oppression of the function of the hypothalamic-pituitary-adrenal system due to the use of local GCS than adults, because of the greater correlation between their body surface area and weight and, accordingly, increased absorption of the drug.

Suppression of hypothalamic-pituitary-adrenal system function in children is determined by low plasma cortisol level and lack of response to stimulation of adrenocorticotropic hormone.
Increase in intracranial pressure is manifested by protrusion of the fontanel, headaches, bilateral edema of the optic disc.
OVERDOSE

Symptoms: prolonged use of GCS for topical administration in elevated doses can cause suppression of the pituitary-adrenal system leading to secondary adrenal insufficiency and hypercorticoid phenomena, including Cushing's syndrome.

Long-term use of salicylic acid preparations for topical administration in elevated doses can cause symptoms of salicylate poisoning (early symptoms - nausea and vomiting).

Treatment: symptomatic.

When overdose GCS - if necessary - correction of electrolyte imbalance.
When poisoning with salicylic acid, it is necessary to take measures to rapidly remove salicylic acid from the body, for example, ingestion of sodium bicarbonate - for urine alkalinization and forcing diuresis.
TERMS OF RELEASE FROM PHARMACY

The drug is approved for use as a means of OTC.

TERMS AND CONDITIONS OF STORAGE

Keep out of reach of children, at a temperature of 2 to 25 В° C.

Shelf life - 2 years.
Do not use the drug after the expiration date.
Alphabetical index of medicines:
A  B  V  G  D  E  J
Z  I  Y  K  L  M  N
O  P  R  S  T  U  F
H  C  CH  SH  E  U  Y

Privacy policy:
Copyright 2009 - 2017. Universal reference book of medicines. All rights reserved.
When using site materials, an active hyperlink is required!